300006 萊美藥業
按盤價 
4.050 -0.500 (-10.989%)
4.050 -0.500 (-10.989%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -1.277 | -0.425 | -3.210 | -6.042 | -23.960 |
| 總資產報酬率 ROA (%) | -0.891 | -0.300 | -2.297 | -3.310 | -9.829 |
| 投入資產回報率 ROIC (%) | -1.071 | -0.360 | -2.799 | -4.112 | -12.272 | 邊際利潤分析 |
| 銷售毛利率 (%) | 63.401 | 69.330 | 73.498 | 71.466 | 68.089 |
| 營業利潤率 (%) | -6.738 | 6.278 | -10.857 | -5.725 | -21.856 |
| 息稅前利潤/營業總收入 (%) | -4.076 | -2.123 | -7.963 | -7.057 | -16.340 |
| 淨利潤/營業總收入 (%) | -2.563 | -1.119 | -8.624 | -8.646 | -21.765 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 506.545 | -2,145.438 | 151.840 | 119.260 | 51.999 |
| 價值變動淨收益/利潤總額(%) | 165.658 | 2,421.015 | -7.682 | -45.226 | -0.983 |
| 營業外收支淨額/利潤總額(%) | -281.434 | -1,464.312 | -27.631 | 33.806 | -0.724 | 償債能力分析 |
| 流動比率 (X) | 2.355 | 2.928 | 2.489 | 2.590 | 0.997 |
| 速動比率 (X) | 2.108 | 2.624 | 2.201 | 2.353 | 0.823 |
| 資產負債率 (%) | 30.600 | 26.591 | 28.483 | 24.418 | 60.874 |
| 帶息債務/全部投入資本 (%) | 16.333 | 11.579 | 14.840 | 7.790 | 46.932 |
| 股東權益/帶息債務 (%) | 505.206 | 735.392 | 568.487 | 1,157.975 | 99.850 |
| 股東權益/負債合計 (%) | 221.208 | 270.667 | 244.128 | 301.736 | 61.128 |
| 利息保障倍數 (X) | 1.765 | 0.841 | -14.654 | -4.432 | -3.049 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 136.557 | 131.612 | 153.285 | 133.152 | 127.609 |
| 存貨周轉天數 (天) | 221.487 | 244.692 | 276.541 | 233.973 | 218.488 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 27/12/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
